356 related articles for article (PubMed ID: 17320979)
21. [Isolation and study of the immunobiological properties of the recombinant proteins of measles virus].
Kulak MV; Netesova NA; Belavin PA; Seregina EV; Ignat'ev GM
Mol Gen Mikrobiol Virusol; 2008; (1):34-7. PubMed ID: 18368780
[TBL] [Abstract][Full Text] [Related]
22. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody.
Lee MS; Cohen B; Hand J; Nokes DJ
J Virol Methods; 1999 Mar; 78(1-2):209-17. PubMed ID: 10204711
[TBL] [Abstract][Full Text] [Related]
23. Determination of immunity to measles virus in young adults: comparative evaluation of a commercial enzyme immunoassay and the hemagglutination inhibition techniques.
Duvdevani P; Varsano N; Slepon R; Lerman Y; Shohat T; Mendelson E
Clin Diagn Virol; 1996 Oct; 7(1):1-6. PubMed ID: 9077425
[TBL] [Abstract][Full Text] [Related]
24. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.
Khawplod P; Inoue K; Shoji Y; Wilde H; Ubol S; Nishizono A; Kurane I; Morimoto K
J Virol Methods; 2005 Apr; 125(1):35-40. PubMed ID: 15737414
[TBL] [Abstract][Full Text] [Related]
25. Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus.
Callagy SJ; Kelly BJ; Fleeton MN; Sheahan BJ; Galbraith SE; Atkins GJ
Vaccine; 2007 Oct; 25(43):7481-90. PubMed ID: 17905485
[TBL] [Abstract][Full Text] [Related]
26. Mapping of B cell epitopes in measles virus nucleocapsid protein.
Zvirbliene A; Kucinskaite I; Sezaite I; Samuel D; Sasnauskas K
Arch Virol; 2007 Jan; 152(1):25-39. PubMed ID: 16944047
[TBL] [Abstract][Full Text] [Related]
27. Comparison of five methods for the detection of measles specific immunoglobulin G antibody.
Vázquez-Rosales JG; Solórzano-Santos F; Bustamante-Calvillo ME; Torres-López J; Díaz-Ponce H; Muñoz O; Alvarez-Muñoz MT
Rev Latinoam Microbiol; 1996; 38(3-4):167-75. PubMed ID: 10932707
[TBL] [Abstract][Full Text] [Related]
28. [Investigation of antibodies against measles antigen in institutionalized patients with severe motor and intellectual disability].
Machida Y; Yamamoto J; Yano Y; Yano T
Kansenshogaku Zasshi; 2008 Jul; 82(4):328-34. PubMed ID: 18697485
[TBL] [Abstract][Full Text] [Related]
29. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
[TBL] [Abstract][Full Text] [Related]
30. [EIA-IgG antibody measles prevention level estimated from measles neutralizing, particle agglutination and hemagglutination-inhibition antibody titer].
Takayama N; Saika S; Ichinohe S
Kansenshogaku Zasshi; 2009 Sep; 83(5):519-24. PubMed ID: 19860253
[TBL] [Abstract][Full Text] [Related]
31. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
Johnson MC; Damon IK; Karem KL
J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
[TBL] [Abstract][Full Text] [Related]
32. Wild measles virus strain: isolation and identification.
Tikhonova NT; Mamaeva TA; Naumova MA; Leschinskaja EV; Volkov MV; Martynenko IM
Acta Virol; 1992 Dec; 36(6):557-66. PubMed ID: 1363990
[TBL] [Abstract][Full Text] [Related]
33. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
de Swart RL; Yüksel S; Osterhaus AD
J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
[TBL] [Abstract][Full Text] [Related]
34. Humoral immunity and correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis virus in children.
Venturi G; Mel R; Marchi A; Mancuso S; Russino F; Pra GD; Papa N; Bertiato G; Fiorentini C; Ciufolini MG
J Virol Methods; 2006 Jun; 134(1-2):136-9. PubMed ID: 16458368
[TBL] [Abstract][Full Text] [Related]
35. Humoral immunity in natural infection by tick-borne encephalitis virus.
Venturi G; Martelli P; Mazzolini E; Fiorentini C; Benedetti E; Todone D; Villalta D; Fortuna C; Marchi A; Minelli G; Ciufolini MG
J Med Virol; 2009 Apr; 81(4):665-71. PubMed ID: 19235849
[TBL] [Abstract][Full Text] [Related]
36. Enzyme immunoassay--a method of serological survey of measles vaccination.
Vedunova SL; Mikheeva IV; Maltseva NN
Acta Virol; 1990 Feb; 34(1):95-8. PubMed ID: 1975731
[TBL] [Abstract][Full Text] [Related]
37. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination.
Cohen BJ; Audet S; Andrews N; Beeler J;
Vaccine; 2007 Dec; 26(1):59-66. PubMed ID: 18063236
[TBL] [Abstract][Full Text] [Related]
38. Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein.
Kumada A; Komase K; Nakayama T
Vaccine; 2004 Jan; 22(3-4):309-16. PubMed ID: 14670311
[TBL] [Abstract][Full Text] [Related]
39. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA
Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223
[TBL] [Abstract][Full Text] [Related]
40. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
Weigle KA; Murphy MD; Brunell PA
J Clin Microbiol; 1984 Mar; 19(3):376-9. PubMed ID: 6371044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
